🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate and compare the efficacy and safet...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00276458
Treatments Being Tested
Primary Objective: To demonstrate the reduction of low-density lipoprotein...
Status
Completed
Location
Investigational Site Number 392028
Start Date
2015-11-30
Trial ID
NCT02584504
Treatments Being Tested
The study aims to compare the potential benefit of allopurinol versus atorv...
Status
Completed
Location
Tanta University
Start Date
2022-11-15
Trial ID
NCT05511766
Treatments Being Tested
This study is the first and largest secondary prevention trial about lipid-...
Status
Not Yet Recruiting
Location
Yunyang County People's Hospital
Start Date
2023-01
Trial ID
NCT05589454
Treatments Being Tested
This randomized controlled clinical study aims to evaluate the effect of Mo...
Status
Completed
Location
The First Affiliated Hospital of Heilongjiang University of Chinese Medicine
Start Date
2023-10-01
Trial ID
NCT07702669
Treatments Being Tested
The purpose of this study is to determine the efficacy of lapaquistat aceta...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00864643
Treatments Being Tested
The purpose of this study is to determine whether ezetimibe/atorvastatin 10...
Status
Completed
Location
Multiple Locations
Start Date
2011-09
Trial ID
NCT01370590
The purpose of this study is to determine how different doses of a statin a...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2018-02-01
Trial ID
NCT03360916
Treatments Being Tested
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
This is a randomized, double-blind, active-comparator, parallel-group study...
Status
Completed
Location
Multiple Locations
Start Date
2012-10
Trial ID
NCT01730040
Treatments Being Tested